Dear Colleagues --
Today a team of researchers published an article on unapproved pharmaceuticals found in dietary supplements. The study reports on dietary supplements associated with this type of spiking from 2007-2016. The data clearly shows there are three areas that dominate the spiked DS market: sexual enhancement, weight loss, and muscle building, with the first two accounting for nearly 90% of total.
In an associated article, Dr. Pieter Cohen, well known to UNPA members, published an op-ed piece noting the health risks such products present to consumers. Dr. Cohen further observes that FDA's inability or unwillingness to aggressively address this problem is disappointing. He concludes with the suggestion that dietary supplement product registration with FDA would effectively and swiftly remove such products from the market.
Finally, I attach an NPR article just released, reporting on this study and opinion piece. Interestingly, my e-mail in-box header for this NPR story reads, "Viagra, common steroids, and more, appear in products marketed as 'natural'" -- which NPR no doubt judged to be a more interesting headline.
We expect there will be substantial news coverage on this. Given the torrid news cycle these days, I expect this will drop off the front page by early next week. Nevertheless, there appears to be growing interest to address this issue and related challenges through product registration or other "corrections" to DSHEA. How that might happen will be a matter of internal UNPA discussion as well as conversations between associations and industry members.